Deciphering the underlying mechanism of Xianlinggubao capsule against osteoporosis by network pharmacology

BACKGROUND: Xianlinggubao formula (XLGB), a Chinese State Food and Drug Administration-permitted traditional Chinese herbal medicine, has been extensively used to treat osteoporosis. Although XLGB was shown to improve bone mass in ovariectomized rats and clinically alleviate osteoporosis symptoms, i...

Descripción completa

Detalles Bibliográficos
Autores principales: Bao, Hangsheng, Guo, Huizhi, Feng, Zongquan, Li, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333287/
https://www.ncbi.nlm.nih.gov/pubmed/32620113
http://dx.doi.org/10.1186/s12906-020-03007-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333287/
https://www.ncbi.nlm.nih.gov/pubmed/32620113
http://dx.doi.org/10.1186/s12906-020-03007-1

Ejemplares similares